Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial. - Ureshino H; Murai K; Kumagai T; Mino T; Nishiwaki K; Wakita S; Takeoka T; Mita M; Yoshida C; Uoshima N; Fukushima T; Kuroda J; et al. (Blood cancer journal, 2026)